Trials / Completed
CompletedNCT05669924
Neural Correlates of Acute Pain Dynamics
The Neural Correlates of and Effects of Methylphenidate on Acute Pain Dynamics
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This work aims to study the neural correlates and determinants of pain dynamics related to changes in a noxious stimulus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylphenidate | 0.35 mg/kg methylphenidate will be administered after baseline testing and 45 min-1 hr before post-intervention testing. |
| DRUG | Placebo | Placebo for methylphenidate |
Timeline
- Start date
- 2022-09-19
- Primary completion
- 2024-04-26
- Completion
- 2024-04-26
- First posted
- 2023-01-03
- Last updated
- 2024-05-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05669924. Inclusion in this directory is not an endorsement.